Vici P - Search Results

1

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios.

Pizzuti L, Krasniqi E, Barchiesi G, Mazzotta M, Barba M, Amodio A, Massimiani G, Pelle F, Kayal R, Vizza E, Grassadonia A, Tomao S, Venuti A, Gamucci T, Marchetti P, Natoli C, Sanguineti G, Ciliberto G, Vici P. Pizzuti L, et al. Among authors: vici p. J Cancer. 2019 Oct 12;10(24):5903-5914. doi: 10.7150/jca.35109. eCollection 2019. J Cancer. 2019. PMID: 31762800 Free PMC article. Review.

2

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.

Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. Among authors: vici p. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Clinical Trial.

3

Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.

Lopez M, Natali M, Di Lauro L, Vici P, Pignatti F, Carpano S. Lopez M, et al. Among authors: vici p. Cancer. 1993 Jul 15;72(2):502-5. doi: 10.1002/1097-0142(19930715)72:2<502::aid-cncr2820720228>3.0.co;2-1. Cancer. 1993. PMID: 8319180

4

Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.

Vici P, Di Lauro L, Carpano S, Amodio A, Pignatti F, Casali A, Conti F, Lopez M. Vici P, et al. Oncology. 1996 Jan-Feb;53(1):16-8. doi: 10.1159/000227528. Oncology. 1996. PMID: 8570125 Clinical Trial.

5

Paclitaxel activity in anthracycline refractory breast cancer patients.

Vici P, Di Lauro L, Conti F, Capomolla E, Gionfra T, Amodio A, Lopez M. Vici P, et al. Tumori. 1997 May-Jun;83(3):661-4. doi: 10.1177/030089169708300307. Tumori. 1997. PMID: 9267484 Clinical Trial.

6

First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.

Vici P, Amodio A, Di Lauro L, Conti F, Gionfra T, Belli F, Lopez M. Vici P, et al. Oncology. 2000;58(1):3-7. doi: 10.1159/000012071. Oncology. 2000. PMID: 10644933 Clinical Trial.

7

Docetaxel in patients with anthracycline-resistant advanced breast cancer.

Vici P, Belli F, Di Lauro L, Amodio A, Conti F, Foggi P, Gionfra T, Morelli MF, Botti C, Ferraironi A, Lopez M. Vici P, et al. Oncology. 2001;60(1):60-5. doi: 10.1159/000055298. Oncology. 2001. PMID: 11150910 Clinical Trial.

8

First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.

Vici P, Colucci G, Gebbia V, Amodio A, Giotta F, Belli F, Conti F, Gebbia N, Pezzella G, Valerio MR, Brandi M, Pisconti S, Durini E, Giannarelli D, Lopez M. Vici P, et al. J Clin Oncol. 2002 Jun 1;20(11):2689-94. doi: 10.1200/JCO.2002.06.039. J Clin Oncol. 2002. PMID: 12039931 Clinical Trial.

9

Recent advances in the adjuvant treatment of early breast cancer.

De Luca C, Vici P, Carpano S, Sergi D, Viola G, Corsetti S, Toglia G, Pinnarò P, Vizza E, Amodio A, Paoletti G, Lopez M. De Luca C, et al. Among authors: vici p. Clin Ter. 2009;160(4):299-306. Clin Ter. 2009. PMID: 19795084 Review.

10

In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy.

Metro G, Zheng Z, Fabi A, Schell M, Antoniani B, Mottolese M, Monteiro AN, Vici P, Lara Rivera S, Boulware D, Cognetti F, Bepler G. Metro G, et al. Among authors: vici p. Cancer Invest. 2010 Feb;28(2):172-80. doi: 10.3109/07357900903095722. Cancer Invest. 2010. PMID: 19968494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page